Anthem Biosciences
ANTHEM · Pharma > Pharmaceuticals & Drugs Listing date: July 21, 2025

Stock Price vs Company Growth
1d
2.7%
1w
3.9%
1m
14.1%
3m
25.6%
6m
43.5%
1y
17.8%
all
27.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 959 2.7%
735
971
Company Overview

Sales
2,002 Cr
Growth: 15.7%
Profit after Tax
575 Cr
Growth: -2.7%
Large Cap
54,042 Cr
P/E: 94.5x
Industry P/E: 34.2x
Fundamentals

Sales (Cr) ₹ 2,002
Growth 15.7%
EBITDA 39.6%
P/S 27.0x
Dividend 0.0%
P/E 94.5x
Book Value ₹ 56.1
PEG Ratio 5.9x
ROE 19.6%
P/B 16.6x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Anthem Biosciences has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries. Awards, accreditations, and recognition2023: Received a certificate of recognition as a ‘Four Star Export House’ from the Ministry of Commerce and Industry.
Investors (1)
Followers (1)